Vitamin D deficiency is very common in the U.S.
The most common reasons for vitamin D deficiency include: lack of sun exposure and regular use of sunscreen. Individuals with darker pigmented skin are at greater risk for vitamin D deficiency.
Chronic liver disease and kidney failure are risk factors for vitamin D deficiency.
Patients who present with hypercalcemia, hyperphosphatemia, and low PTH may suffer from unregulated conversion of 25-OH-VitD to 1,25-OHD.
Some medications can deplete vitamin D: anti-inflammatory medications, antibiotics, anticonvulsant medications, cholesterol lowering medications, laxatives and anti-ulcer medications.
Conditions that have been associated with low vitamin D status include: Alzheimer’s disease, asthma, autism, cancer, cavities, colds and flus, cystic fibrosis, dementia, depression, diabetes 1 and 2, eczema and psoriasis, hearing loss, heart disease, hypertension, infertility, inflammatory bowel disease, insomnia, macular degeneration, migraines, multiple sclerosis, Crohn’s disease, muscle pain, obesity, osteomalacia, osteoporosis, periodontal disease, preeclampsia, rheumatoid arthritis, schizophrenia, seizures, septicemia, and tuberculosis.
Reasons for suboptimal 25-OHD levels, specifically, include lack of sun exposure (particularly in northern latitudes and during the winter season), malabsorption (due to Celiac disease, or other inflammatory digestive disorders), inadequate hepatic vitamin D 25-hydroxylase enzyme activity, and some prescription medications such as antiepileptic drugs, including phenytoin, phenobarbital, and carbamazepine, that increase 25-OHD metabolism.
Levels of PTH may be high-normal or elevated in sub-clinical and frank vitamin D deficiency.
The previously established RDA of 400IU/day has been found to be insufficient for therapeutic needs. Common doses are used between 1000 and 10,000 IU/day.
Vitamin D comes in two forms: D2 (ergocalciferol) and D3 (cholecalciferol); both forms can be converted to active vitamin D in the body (25-hydroxyvitamin D).
Vitamin D is produced when skin is exposed to ultraviolet light from the sun.
Supplementation with Vitamin D is almost always necessary, as it is extremely difficult to meet needs though diet and sun exposure alone. Consult with your practitioner for supplement recommendations and target goal for serum levels.
Because vitamin D can be stored or trapped in adipose tissue (fat cells) obese individuals and pregnant women have higher vitamin D requirements.
Obtaining too much vitamin D from sun exposure is not possible, but it is possible to obtain too much from supplementation.
Taking too much vitamin D in supplement form can also cause in increase in blood levels of calcium, or hypercalcemia, due to increased intestinal absorption of calcium when serum vitamin D levels are high.
Vitamin D toxicity has been observed in individuals taking greater than 50,000 IU/day, but intake levels less than 10,000 IU/day are unlikely to cause toxicity.
25-hydroxyvitamin D is a standard lab test which measures the inactive precursor to 1,25-OHD, which is a combination of two forms of vitamin D in the body: vitamin D2 and vitamin D3.
25-OHD has a longer half-life in the blood than 1,25-OHD, and, therefore, levels may differ from levels of active 1,25-OHD3.
Because 25-OHD is a precursor to active forms of vitamin D, it is important to note that it is not reflective of overall active D3 levels, but rather what is available for conversion if cofactors are sufficient.
The conversion of 25-OHD to 1,25-OHD is performed in the kidneys and regulated by parathyroid hormone (PTH). When blood calcium levels fall, PTH signals the kidneys to convert more 25-OHD to 1,25-OHD, which increases intestinal absorption of calcium, and reduces bone demineralization of calcium.